How can STPs support local manufacturing SMEs to tackle for new innovation in fast growing life science research market? Lessons learned from KRP's challenge

In the commercialization of technology, most ordinary model is to utilize the technology from research institutions, such as universities. In this model, entrepreneurs and companies are the ones who know the customer needs, and will be players to commercialize this technology.Kyoto Research Park (KRP), has found new innovative model for commercialization of technology.In our case, the technologies of the regional SMEs are utilized, and the customer needs are given from the researchers.In this paper, we will introduce our commercialization activity in one of the hottest life science areas, which are stem cell and tissue engineering researches. KRP has combined 3 strategic phases to support SMEs to challenge this market; information support, prototyping support, and commercialization support.We will identify our activities and the key factors. KRP wishes to share our lessons learned to accelerate regional innovation with SMEs as main players of innovation.